Skip to content
2000
Volume 32, Issue 39
  • ISSN: 0929-8673
  • E-ISSN: 1875-533X

Abstract

Hypertension is a modifiable cardiovascular risk factor and displays a rapidly growing incidence due to aging and the acquisition of an unhealthy lifestyle. Hypertension is linked to the development of target organ damage in several vascular beds such as coronary arteries, peripheral, cerebral, and renal arteries. Besides, along with the presence of other cardiovascular risk factors, it aggravates vascular dysfunction due to the aging process. The mechanisms of vascular dysfunction in hypertension are complex and involve excessive salt intake and water retention, activation of neurohormonal systems, induction of endothelial dysfunction of large arteries and microcirculation, development of arterial stiffness, and complex interactions with cellular pathways of inflammation, oxidative stress, and thrombosis. The extent of vascular dysfunction in patients with hypertension can be assessed by evaluating endothelial function, measuring arterial stiffness, and testing the levels of circulating biomarkers of oxidative stress, pro-inflammatory cytokines, and thrombosis. Assessing these markers in subjects with and without hypertension could aid in identifying those at risk of vascular damage and improving risk prediction for future cardiovascular events. While several lifestyle and pharmacological therapies have shown promise in addressing vascular dysfunction in hypertension, none of these biomarkers have been established as an independent risk factor or treatment target. Therefore, in this article, we review the literature on the evidence that exists regarding the role of vascular dysfunction in the pathophysiology, diagnosis, progression, and treatment of hypertension, highlighting the lack of conclusive evidence in this field.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cmc/10.2174/0109298673311734240718064511
2024-07-25
2025-10-18

  • From This Site

    /content/journals/cmc/10.2174/0109298673311734240718064511
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. RothG.A. MensahG.A. JohnsonC.O. AddoloratoG. AmmiratiE. BaddourL.M. BarengoN.C. BeatonA.Z. BenjaminE.J. BenzigerC.P. BonnyA. BrauerM. BrodmannM. CahillT.J. CarapetisJ. CatapanoA.L. ChughS.S. CooperL.T. CoreshJ. CriquiM. DeCleeneN. EagleK.A. Emmons-BellS. FeiginV.L. Fernández-SolàJ. FowkesG. GakidouE. GrundyS.M. HeF.J. HowardG. HuF. InkerL. KarthikeyanG. KassebaumN. KoroshetzW. LavieC. Lloyd-JonesD. LuH.S. MirijelloA. TemesgenA.M. MokdadA. MoranA.E. MuntnerP. NarulaJ. NealB. NtsekheM. Moraes de OliveiraG. OttoC. OwolabiM. PrattM. RajagopalanS. ReitsmaM. RibeiroA.L.P. RigottiN. RodgersA. SableC. ShakilS. Sliwa-HahnleK. StarkB. SundströmJ. TimpelP. TleyjehI.M. ValgimigliM. VosT. WheltonP.K. YacoubM. ZuhlkeL. MurrayC. FusterV. RothG.A. MensahG.A. JohnsonC.O. AddoloratoG. AmmiratiE. BaddourL.M. BarengoN.C. BeatonA. BenjaminE.J. BenzigerC.P. BonnyA. BrauerM. BrodmannM. CahillT.J. CarapetisJ.R. CatapanoA.L. ChughS. CooperL.T. CoreshJ. CriquiM.H. DeCleeneN.K. EagleK.A. Emmons-BellS. FeiginV.L. Fernández-SolaJ. FowkesF.G.R. GakidouE. GrundyS.M. HeF.J. HowardG. HuF. InkerL. KarthikeyanG. KassebaumN.J. KoroshetzW.J. LavieC. Lloyd-JonesD. LuH.S. MirijelloA. MisganawA.T. MokdadA.H. MoranA.E. MuntnerP. NarulaJ. NealB. NtsekheM. OliveiraG.M.M. OttoC.M. OwolabiM.O. PrattM. RajagopalanS. ReitsmaM.B. RibeiroA.L.P. RigottiN.A. RodgersA. SableC.A. ShakilS.S. SliwaK. StarkB.A. SundströmJ. TimpelP. TleyjehI.I. ValgimigliM. VosT. WheltonP.K. YacoubM. ZuhlkeL.J. Abbasi-KangevariM. AbdiA. AbediA. AboyansV. AbrhaW.A. Abu-GharbiehE. AbushoukA.I. AcharyaD. AdairT. AdebayoO.M. AdemiZ. AdvaniS.M. AfshariK. AfshinA. AgarwalG. AgasthiP. AhmadS. AhmadiS. AhmedM.B. AjiB. AkaluY. Akande-SholabiW. AkliluA. AkunnaC.J. AlahdabF. Al-EyadhyA. AlhabibK.F. AlifS.M. AlipourV. AljunidS.M. AllaF. Almasi-HashianiA. AlmustanyirS. Al-RaddadiR.M. AmegahA.K. AminiS. AminorroayaA. AmuH. AmugsiD.A. AncuceanuR. AnderliniD. AndreiT. AndreiC.L. Ansari-MoghaddamA. AntenehZ.A. AntonazzoI.C. AntonyB. AnwerR. AppiahL.T. ArablooJ. ÄrnlövJ. ArtantiK.D. AtaroZ. AusloosM. Avila-BurgosL. AwanA.T. AwokeM.A. AyeleH.T. AyzaM.A. AzariS. BD.B. BaheiraeiN. BaigA.A. BakhtiariA. BanachM. BanikP.C. BaptistaE.A. BarbozaM.A. BaruaL. BasuS. BediN. BéjotY. BennettD.A. BensenorI.M. BermanA.E. BezabihY.M. BhagavathulaA.S. BhaskarS. BhattacharyyaK. BijaniA. BikbovB. BirhanuM.M. BoloorA. BrantL.C. BrennerH. BrikoN.I. ButtZ.A. Caetano dos SantosF.L. CahillL.E. Cahuana-HurtadoL. CámeraL.A. Campos-NonatoI.R. Cantu-BritoC. CarJ. CarreroJ.J. CarvalhoF. Castañeda-OrjuelaC.A. Catalá-LópezF. CerinE. CharanJ. ChattuV.K. ChenS. ChinK.L. ChoiJ-Y.J. ChuD-T. ChungS-C. CirilloM. CoffeyS. ContiS. CostaV.M. CundiffD.K. DadrasO. DagnewB. DaiX. DamascenoA.A.M. DandonaL. DandonaR. DavletovK. De la Cruz-GóngoraV. De la HozF.P. De NeveJ-W. Denova-GutiérrezE. Derbew MollaM. DersehB.T. DesaiR. DeuschlG. DharmaratneS.D. DhimalM. DhunganaR.R. DianatinasabM. DiazD. DjalaliniaS. DokovaK. DouiriA. DuncanB.B. DuraesA.R. EaganA.W. EbtehajS. EftekhariA. EftekharzadehS. EkholuenetaleM. El NahasN. ElgendyI.Y. ElhadiM. El-JaafaryS.I. EsteghamatiS. EtissoA.E. EyawoO. FadhilI. FaraonE.J.A. FarisP.S. FarwatiM. FarzadfarF. FernandesE. Fernandez PrendesC. FerraraP. FilipI. FischerF. FloodD. FukumotoT. GadM.M. GaidhaneS. GanjiM. GargJ. GebreA.K. GebregiorgisB.G. GebregzabiherK.Z. GebremeskelG.G. GetacherL. ObsaA.G. GhajarA. GhashghaeeA. GhithN. GiampaoliS. GilaniS.A. GillP.S. GillumR.F. GlushkovaE.V. GnedovskayaE.V. GolechhaM. GonfaK.B. GoudarzianA.H. GoulartA.C. GuadamuzJ.S. GuhaA. GuoY. GuptaR. HachinskiV. Hafezi-NejadN. HaileT.G. HamadehR.R. HamidiS. HankeyG.J. HargonoA. HartonoR.K. HashemianM. HashiA. HassanS. HassenH.Y. HavmoellerR.J. HayS.I. HayatK. HeidariG. HerteliuC. HollaR. HosseiniM. HosseinzadehM. HostiucM. HostiucS. HousehM. HuangJ. HumayunA. IavicoliI. IbenemeC.U. IbitoyeS.E. IlesanmiO.S. IlicI.M. IlicM.D. IqbalU. IrvaniS.S.N. IslamS.M.S. IslamR.M. IsoH. IwagamiM. JainV. JavaheriT. JayapalS.K. JayaramS. JayawardenaR. JeemonP. JhaR.P. JonasJ.B. JonnagaddalaJ. JoukarF. JozwiakJ.J. JürissonM. KabirA. KahlonT. KalaniR. KalhorR. KamathA. KamelI. KandelH. KandelA. KarchA. KasaA.S. KatotoP.D.M.C. KayodeG.A. KhaderY.S. KhammarniaM. KhanM.S. KhanM.N. KhanM. KhanE.A. KhatabK. KibriaG.M.A. KimY.J. KimG.R. KimokotiR.W. KisaS. KisaA. KivimäkiM. KolteD. KoolivandA. KorshunovV.A. Koulmane LaxminarayanaS.L. KoyanagiA. KrishanK. KrishnamoorthyV. Kuate DefoB. Kucuk BicerB. KulkarniV. KumarG.A. KumarN. KurmiO.P. KusumaD. KwanG.F. La VecchiaC. LaceyB. LallukkaT. LanQ. LasradoS. LassiZ.S. LauriolaP. LawrenceW.R. LaxmaiahA. LeGrandK.E. LiM-C. LiB. LiS. LimS.S. LimL-L. LinH. LinZ. LinR-T. LiuX. LopezA.D. LorkowskiS. LotufoP.A. LugoA. MN.K. MadottoF. MahmoudiM. MajeedA. MalekzadehR. MalikA.A. MamunA.A. ManafiN. MansourniaM.A. MantovaniL.G. MartiniS. MathurM.R. MazzagliaG. MehataS. MehndirattaM.M. MeierT. MenezesR.G. MeretojaA. MestrovicT. MiazgowskiB. MiazgowskiT. MichalekI.M. MillerT.R. MirrakhimovE.M. MirzaeiH. MoazenB. MoghadaszadehM. MohammadY. MohammadD.K. MohammedS. MohammedM.A. MokhayeriY. MolokhiaM. MontasirA.A. MoradiG. MoradzadehR. MoragaP. MorawskaL. Moreno VelásquezI. MorzeJ. MubarikS. MuruetW. MusaK.I. NagarajanA.J. NaliniM. NangiaV. NaqviA.A. Narasimha SwamyS. NascimentoB.R. NayakV.C. NazariJ. NazarzadehM. NegoiR.I. Neupane KandelS. NguyenH.L.T. NixonM.R. NorrvingB. NoubiapJ.J. NoutheB.E. NowakC. OdukoyaO.O. OgboF.A. OlagunjuA.T. OrruH. OrtizA. OstroffS.M. PadubidriJ.R. PalladinoR. PanaA. Panda-JonasS. ParekhU. ParkE-C. ParviziM. Pashazadeh KanF. PatelU.K. PathakM. PaudelR. PepitoV.C.F. PerianayagamA. PericoN. PhamH.Q. PilgrimT. PiradovM.A. PishgarF. PodderV. PolibinR.V. PourshamsA. PribadiD.R.A. RabieeN. RabieeM. RadfarA. RafieiA. RahimF. Rahimi-MovagharV. Ur RahmanM.H. RahmanM.A. RahmaniA.M. RakovacI. RamP. RamalingamS. RanaJ. RanasingheP. RaoS.J. RathiP. RawalL. RawasiaW.F. RawassizadehR. RemuzziG. RenzahoA.M.N. RezapourA. RiahiS.M. Roberts-ThomsonR.L. RoeverL. RohloffP. RomoliM. RoshandelG. RwegereraG.M. SaadatagahS. Saber-AyadM.M. SabourS. SaccoS. SadeghiM. Saeedi MoghaddamS. SafariS. SahebkarA. SalehiS. SalimzadehH. SamaeiM. SamyA.M. SantosI.S. Santric-MilicevicM.M. SarrafzadeganN. SarveazadA. SathishT. SawhneyM. SaylanM. SchmidtM.I. SchutteA.E. SenthilkumaranS. SepanlouS.G. ShaF. ShahabiS. ShahidI. ShaikhM.A. ShamaliM. ShamsizadehM. ShawonM.S.R. SheikhA. ShigematsuM. ShinM-J. ShinJ.I. ShiriR. ShiueI. ShuvalK. SiabaniS. SiddiqiT.J. SilvaD.A.S. SinghJ.A. MtechA.S. SkryabinV.Y. SkryabinaA.A. SoheiliA. SpurlockE.E. StockfeltL. StorteckyS. StrangesS. Suliankatchi AbdulkaderR. TadbiriH. TadesseE.G. TadesseD.B. TajdiniM. TariqujjamanM. TeklehaimanotB.F. TemsahM-H. TesemaA.K. ThakurB. ThankappanK.R. ThaparR. ThriftA.G. TimalsinaB. TonelliM. TouvierM. Tovani-PaloneM.R. TripathiA. TripathyJ.P. TruelsenT.C. TsegayG.M. TsegayeG.W. TsilimparisN. TusaB.S. TyrovolasS. UmapathiK.K. UnimB. UnnikrishnanB. UsmanM.S. VaduganathanM. ValdezP.R. VasankariT.J. VelazquezD.Z. VenketasubramanianN. VuG.T. VujcicI.S. WaheedY. WangY. WangF. WeiJ. WeintraubR.G. WeldemariamA.H. WestermanR. WinklerA.S. WiysongeC.S. WolfeC.D.A. WubishetB.L. XuG. YadollahpourA. YamagishiK. YanL.L. YandrapalliS. YanoY. YatsuyaH. YeheyisT.Y. YeshawY. YilgwanC.S. YonemotoN. YuC. YusefzadehH. ZachariahG. ZamanS.B. ZamanM.S. ZamanianM. ZandR. ZandifarA. ZarghiA. ZastrozhinM.S. ZastrozhinaA. ZhangZ-J. ZhangY. ZhangW. ZhongC. ZouZ. ZunigaY.M.H. MurrayC.J.L. FusterV. Global burden of cardiovascular diseases and risk factors, 1990–2019.J. Am. Coll. Cardiol.202076252982302110.1016/j.jacc.2020.11.01033309175
     [Google Scholar]
  2. MillsK.T. BundyJ.D. KellyT.N. ReedJ.E. KearneyP.M. ReynoldsK. ChenJ. HeJ. Global disparities of hypertension prevalence and control.Circulation2016134644145010.1161/CIRCULATIONAHA.115.01891227502908
     [Google Scholar]
  3. JordanJ. KurschatC. ReuterH. Arterial hypertension.Dtsch. Arztebl. Int.201811533-3455756830189978
     [Google Scholar]
  4. DevereuxR.B. AldermanM.H. Role of preclinical cardiovascular disease in the evolution from risk factor exposure to development of morbid events.Circulation19938841444145510.1161/01.CIR.88.4.14448403291
     [Google Scholar]
  5. UngerT. BorghiC. CharcharF. KhanN.A. PoulterN.R. PrabhakaranD. RamirezA. SchlaichM. StergiouG.S. TomaszewskiM. WainfordR.D. WilliamsB. SchutteA.E. 2020 International society of hypertension global hypertension practice guidelines.Hypertension20207561334135710.1161/HYPERTENSIONAHA.120.1502632370572
     [Google Scholar]
  6. MaJ. ChenX. Advances in pathogenesis and treatment of essential hypertension.Front. Cardiovasc. Med.20229100385210.3389/fcvm.2022.100385236312252
     [Google Scholar]
  7. HarrisonD.G. CoffmanT.M. WilcoxC.S. Pathophysiology of Hypertension.Circ. Res.2021128784786310.1161/CIRCRESAHA.121.31808233793328
     [Google Scholar]
  8. RobertsC. K. VaziriN. D. BarnardR. J. Protective effects of estrogen on gender-specific development of diet-induced hypertension.J. Appl. Physiol200191520052009
     [Google Scholar]
  9. NappiR.E. ChedrauiP. LambrinoudakiI. SimonciniT. Menopause: a cardiometabolic transition.Lancet Diabetes Endocrinol.202210644245610.1016/S2213‑8587(22)00076‑635525259
     [Google Scholar]
  10. VirdisA. GhiadoniL. SudanoI. BuralliS. SalvettiG. TaddeiS. SalvettiA. Endothelial function in hypertension: role of gender.J. Hypertens. Suppl.2002202S11S1612183843
     [Google Scholar]
  11. NiiranenT.J. SuvilaK. SuppoguN. EbingerJ.E. LimaJ.A.C. Bairey MerzC.N. ChengS. Sex differences in the cardiac effects of early-onset hypertension.Hypertension2019745e52e5310.1161/HYPERTENSIONAHA.119.1380931564163
     [Google Scholar]
  12. TomiyamaH. Vascular function: a key player in hypertension.Hypertens. Res.20234692145215810.1038/s41440‑023‑01354‑337369849
     [Google Scholar]
  13. ParkJ.B. Hypertensive Vasculopathy.Pulse (Basel)201421-4384110.1159/00036881126587442
     [Google Scholar]
  14. GonzalezM.A. SelwynA.P. Endothelial function, inflammation, and prognosis in cardiovascular disease.Am. J. Med.20031158Suppl. 8A9910610.1016/j.amjmed.2003.09.01614678874
     [Google Scholar]
  15. KonukogluD. UzunH. Endothelial dysfunction and hypertension.Adv. Exp. Med. Biol.201695651154010.1007/5584_2016_9028035582
     [Google Scholar]
  16. LinY.J. JuanC.C. KwokC.F. HsuY.P. ShihK.C. ChenC.C. HoL.T. Endothelin-1 exacerbates development of hypertension and atherosclerosis in modest insulin resistant syndrome.Biochem. Biophys. Res. Commun.2015460349750310.1016/j.bbrc.2015.03.01725824048
     [Google Scholar]
  17. AramouniK. AssafR. ShaitoA. FardounM. Al-AsmakhM. SahebkarA. EidA.H. Biochemical and cellular basis of oxidative stress: Implications for disease onset.J. Cell. Physiol.202323891951196310.1002/jcp.3107137436042
     [Google Scholar]
  18. RodrigoR. LibuyM. FeliúF. HassonD. Oxidative stress-related biomarkers in essential hypertension and ischemia-reperfusion myocardial damage.Dis. Markers201335677379010.1155/2013/97435824347798
     [Google Scholar]
  19. DikalovaA. FehrenbachD. MayorovV. PanovA. AoM. LantierL. AmarnathV. LopezM.G. BillingsF.T.IV SackM.N. DikalovS. Mitochondrial cypd acetylation promotes endothelial dysfunction and hypertension.Circ. Res.2024134111451146410.1161/CIRCRESAHA.123.32359638639088
     [Google Scholar]
  20. ShaitoA. AramouniK. AssafR. ParentiA. OrekhovA. YazbiA.E. PintusG. EidA.H. Oxidative stress-induced endothelial dysfunction in cardiovascular diseases.Frontiers in Bioscience-Landmark2022273010510.31083/j.fbl270310535345337
     [Google Scholar]
  21. XuM. WangW. ChengJ. QuH. XuM. WangL. Effects of mitochondrial dysfunction on cellular function: Role in atherosclerosis.Biomed. Pharmacother.202417411658710.1016/j.biopha.2024.11658738636397
     [Google Scholar]
  22. CrowleyS.D. The cooperative roles of inflammation and oxidative stress in the pathogenesis of hypertension.Antioxid. Redox Signal.201420110212010.1089/ars.2013.525823472597
     [Google Scholar]
  23. KonukoğluD. SerinÖ. ErcanM. TurhanM.S. Plasma homocysteine levels in obese and non-obese subjects with or without hypertension; its relationship with oxidative stress and copper.Clin. Biochem.200336540540810.1016/S0009‑9120(03)00059‑612849875
     [Google Scholar]
  24. JacobsenJ.C.B. HornbechM.S. Holstein-RathlouN.H. Significance of microvascular remodelling for the vascular flow reserve in hypertension.Interface Focus20111111713110.1098/rsfs.2010.000322419978
     [Google Scholar]
  25. De CiuceisC. RossiniC. La BoriaE. PorteriE. PetroboniB. GavazziA. SarkarA. RoseiE.A. RizzoniD. Immune mechanisms in hypertension.High Blood Press. Cardiovasc. Prev.201421422723410.1007/s40292‑014‑0040‑924446309
     [Google Scholar]
  26. McCarthyC.G. GoulopoulouS. WenceslauC.F. SpitlerK. MatsumotoT. WebbR.C. Toll-like receptors and damage-associated molecular patterns: novel links between inflammation and hypertension.Am. J. Physiol. Heart Circ. Physiol.20143062H184H19610.1152/ajpheart.00328.201324163075
     [Google Scholar]
  27. AboukhaterD. MoradB. NasrallahN. NasserS.A. SahebkarA. KobeissyF. BoudakaA. EidA.H. Inflammation and hypertension: Underlying mechanisms and emerging understandings.J. Cell. Physiol.202323861148115910.1002/jcp.3101937039489
     [Google Scholar]
  28. PapaioannouI. DritsoulaA. KangP. BaligaR.S. TrinderS.L. CookE. ShiwenX. HobbsA.J. DentonC.P. AbrahamD.J. PonticosM. NKX2-5 regulates vessel remodeling in scleroderma-associated pulmonary arterial hypertension.JCI Insight2024910e16419110.1172/jci.insight.16419138652537
     [Google Scholar]
  29. ZdravkovicM. PopadicV. KlasnjaS. KlasnjaA. IvankovicT. LasicaR. LovicD. GostiljacD. VasiljevicZ. Coronary microvascular dysfunction and hypertension: a bond more important than we think.Medicina (Kaunas)20235912214910.3390/medicina5912214938138252
     [Google Scholar]
  30. WójcikM. Kozioł-KozakowskaA. Obesity, sodium homeostasis, and arterial hypertension in children and adolescents.Nutrients20211311403210.3390/nu1311403234836287
     [Google Scholar]
  31. Di DanieleN. MarroneG. Di LauroM. Di DanieleF. PalazzettiD. GuerrieroC. NoceA. Effects of caloric restriction diet on arterial hypertension and endothelial dysfunction.Nutrients202113127410.3390/nu1301027433477912
     [Google Scholar]
  32. Al AttarA.A. FahedG.I. HoballahM.M. PedersenS. El-YazbiA.F. NasserS.A. BittoA. OrekhovA.N. EidA.H. Mechanisms underlying the effects of caloric restriction on hypertension.Biochem. Pharmacol.202220011503510.1016/j.bcp.2022.11503535427570
     [Google Scholar]
  33. YannoutsosA. LevyB.I. SafarM.E. SlamaG. BlacherJ. Pathophysiology of hypertension.J. Hypertens.201432221622410.1097/HJH.000000000000002124270179
     [Google Scholar]
  34. VirdisA. TaddeiS. How to evaluate microvascular organ damage in hypertension: assessment of endothelial function.High Blood Press. Cardiovasc. Prev.201118416316710.2165/11593630‑000000000‑0000022283670
     [Google Scholar]
  35. RossiR. ChiurliaE. NuzzoA. CioniE. OriglianiG. ModenaM.G. Flow-mediated vasodilation and the risk of developing hypertension in healthy postmenopausal women.J. Am. Coll. Cardiol.20044481636164010.1016/j.jacc.2004.07.02715489096
     [Google Scholar]
  36. ZhangY. ThompsonA.M. TongW. XuT. ChenJ. ZhaoL. KellyT.N. ChenC.S. HeJ. Biomarkers of inflammation and endothelial dysfunction and risk of hypertension among Inner Mongolians in China.J. Hypertens.2010281354010.1097/HJH.0b013e328332465019770776
     [Google Scholar]
  37. VarugheseG.I. PatelJ.V. TomsonJ. BlannA.D. HughesE.A. LipG.Y.H. Prognostic value of plasma soluble P-selectin and von Willebrand factor as indices of platelet activation and endothelial damage/dysfunction in high-risk patients with hypertension: a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial.J. Intern. Med.2007261438439110.1111/j.1365‑2796.2007.01770.x17391113
     [Google Scholar]
  38. RossiR. NuzzoA. OlaruA.I. OriglianiG. ModenaM.G. Endothelial function affects early carotid atherosclerosis progression in hypertensive postmenopausal women.J. Hypertens.20112961136114410.1097/HJH.0b013e328345d95021505359
     [Google Scholar]
  39. FelmedenD.C. BlannA.D. SpencerC.G. BeeversD.G. LipG.Y. A comparison of flow-mediated dilatation and von Willebrand factor as markers of endothelial cell function in health and in hypertension.Blood Coagul. Fibrinolysis200314542543110.1097/00001721‑200307000‑0000112851527
     [Google Scholar]
  40. FelmedenD.C. SpencerC.G.C. BlannA.D. BeeversD.G. LipG.Y.H. Low-density lipoprotein subfractions and cardiovascular risk in hypertension: relationship to endothelial dysfunction and effects of treatment.Hypertension200341352853310.1161/01.HYP.0000056997.40992.4112623954
     [Google Scholar]
  41. LipG.Y.H. BlannA.D. EdmundsE. BeeversD.G. Baseline abnormalities of endothelial function and thrombogenesis in relation to prognosis in essential hypertension.Blood Coagul. Fibrinolysis2002131354110.1097/00001721‑200201000‑0000511994565
     [Google Scholar]
  42. LytsyP. LindL. SundströmJ. Endothelial function and risk of hypertension and blood pressure progression.J. Hypertens.201331593693910.1097/HJH.0b013e32835ed5a023391984
     [Google Scholar]
  43. ShimboD. MuntnerP. MannD. VieraA.J. HommaS. PolakJ.F. BarrR.G. HerringtonD. SheaS. Endothelial dysfunction and the risk of hypertension: the multi-ethnic study of atherosclerosis.Hypertension20105551210121610.1161/HYPERTENSIONAHA.109.14312320308612
     [Google Scholar]
  44. BoosC.J. LaneD.A. KarphaM. BeeversD.G. HaynesR. LipG.Y.H. Circulating endothelial cells, arterial stiffness, and cardiovascular risk stratification in hypertension.Chest200713251540154710.1378/chest.07‑042817998358
     [Google Scholar]
  45. PerticoneF. MaioR. SciacquaA. AndreozziF. IemmaG. PerticoneM. ZoccaliC. SestiG. Endothelial dysfunction and C-reactive protein are risk factors for diabetes in essential hypertension.Diabetes200857116717110.2337/db07‑118917928395
     [Google Scholar]
  46. MaioR. PerticoneM. SuraciE. SciacquaA. SestiG. PerticoneF. Endothelial dysfunction and C-reactive protein predict the incidence of heart failure in hypertensive patients.ESC Heart Fail.20218139940710.1002/ehf2.1308833236853
     [Google Scholar]
  47. McCallD.O. McGartlandC.P. WoodsideJ.V. SharpeP. McCanceD.R. YoungI.S. The relationship between microvascular endothelial function and carotid-radial pulse wave velocity in patients with mild hypertension.Clin. Exp. Hypertens.201032747447910.3109/10641963.2010.49651421029013
     [Google Scholar]
  48. TsaiW.C. LiY.H. HuangY.Y. LinC.C. ChaoT.H. ChenJ.H. Plasma vascular endothelial growth factor as a marker for early vascular damage in hypertension.Clin. Sci. (Lond.)20051091394310.1042/CS2004030715740459
     [Google Scholar]
  49. VerhaarM.C. BeutlerJ.J. GaillardC.A. KoomansH.A. FijnheerR. RabelinkT.J. Progressive vascular damage in hypertension is associated with increased levels of circulating P-selectin.J. Hypertens.1998161455010.1097/00004872‑199816010‑000089533416
     [Google Scholar]
  50. JurkoT. MestanikM. MestanikovaA. ZeleňákK. JurkoA. Early signs of microvascular endothelial dysfunction in adolescents with newly diagnosed essential hypertension.Life (Basel)2022127104810.3390/life1207104835888136
     [Google Scholar]
  51. MaruhashiT. SogaJ. FujimuraN. IdeiN. MikamiS. IwamotoY. IwamotoA. KajikawaM. MatsumotoT. OdaN. KishimotoS. MatsuiS. HashimotoH. AibaraY. YusoffF.B.M. HidakaT. KiharaY. ChayamaK. NomaK. NakashimaA. GotoC. TomiyamaH. TakaseB. KohroT. SuzukiT. IshizuT. UedaS. YamazakiT. FurumotoT. KarioK. InoueT. KobaS. WatanabeK. TakemotoY. HanoT. SataM. IshibashiY. NodeK. MaemuraK. OhyaY. FurukawaT. ItoH. IkedaH. YamashinaA. HigashiY. Endothelial function is impaired in patients receiving antihypertensive drug treatment regardless of blood pressure level.Hypertension201770479079710.1161/HYPERTENSIONAHA.117.0961228808069
     [Google Scholar]
  52. JekellA. KalaniM. KahanT. The interrelation of endothelial function and microvascular reactivity in different vascular beds, and risk assessment in hypertension: results from the Doxazosin–ramipril study.Heart Vessels201934348449510.1007/s00380‑018‑1265‑730244381
     [Google Scholar]
  53. ZhouW. BrownJ.M. BajajN.S. ChandraA. DivakaranS. WeberB. BibboC.F. HainerJ. TaquetiV.R. DorbalaS. BlanksteinR. AdlerD. O’GaraP. Di CarliM.F. Hypertensive coronary microvascular dysfunction: a subclinical marker of end organ damage and heart failure.Eur. Heart J.202041252366237510.1093/eurheartj/ehaa19132221588
     [Google Scholar]
  54. GhiadoniL. TaddeiS. VirdisA. SudanoI. Di LeggeV. MeolaM. Di VenanzioL. SalvettiA. Endothelial function and common carotid artery wall thickening in patients with essential hypertension.Hypertension1998321253210.1161/01.HYP.32.1.259674633
     [Google Scholar]
  55. ZoccaliC. Endothelial dysfunction and the kidney: emerging risk factors for renal insufficiency and cardiovascular outcomes in essential hypertension.J. Am. Soc. Nephrol.2006174_suppl_2Suppl. 2S61S6310.1681/ASN.200512134416565249
     [Google Scholar]
  56. KooB.K. ChungW.Y. MoonM.K. Peripheral arterial endothelial dysfunction predicts future cardiovascular events in diabetic patients with albuminuria: a prospective cohort study.Cardiovasc. Diabetol.20201918210.1186/s12933‑020‑01062‑z32534580
     [Google Scholar]
  57. RoumeliotisS. MallamaciF. ZoccaliC. Endothelial dysfunction in chronic kidney disease, from biology to clinical outcomes: A 2020 update.J. Clin. Med.202098235910.3390/jcm908235932718053
     [Google Scholar]
  58. OkuboK. HayashiK. WakinoS. MatsudaH. KubotaE. HondaM. TokuyamaH. YamamotoT. KajiyaF. SarutaT. Role of asymmetrical dimethylarginine in renal microvascular endothelial dysfunction in chronic renal failure with hypertension.Hypertens. Res.200528218118910.1291/hypres.28.18116025746
     [Google Scholar]
  59. ArikanE. SenS. Endothelial damage and hemostatic markers in patients with uncomplicated mild-to-moderate hypertension and relationship with risk factors.Clin. Appl. Thromb. Hemost.200511214715910.1177/10760296050110020415821821
     [Google Scholar]
  60. NadarS.K. BlannA. BeeversD.G. LipG.Y.H. Abnormal angiopoietins 1&2, angiopoietin receptor Tie-2 and vascular endothelial growth factor levels in hypertension: relationship to target organ damage [a sub-study of the anglo-scandinavian cardiac outcomes trial (ASCOT)].J. Intern. Med.2005258433634310.1111/j.1365‑2796.2005.01550.x16164572
     [Google Scholar]
  61. LazzarinN. DesideriG. FerriC. ValensiseH. GagliardiG. TiralongoG.M. ManfellottoD. Hypertension in pregnancy and endothelial activation: An emerging risk factor for cardiovascular disease.Pregnancy Hypertens.20122439339710.1016/j.preghy.2012.02.00226105609
     [Google Scholar]
  62. TrichesC.B. MayerS. QuintoB.M.R. BatistaM.C. ZanellaM.T. Association of endothelial dysfunction with cardiovascular risk factors and new-onset diabetes mellitus in patients with hypertension.J. Clin. Hypertens. (Greenwich)201820593594110.1111/jch.1326929604155
     [Google Scholar]
  63. ZhangH.G. ZhangQ.J. LiB.W. LiL.H. SongX.H. XiongC.M. ZouY.B. LiuB.Y. HanJ.Q. XiuR.J. The circulating level of miR-122 is a potential risk factor for endothelial dysfunction in young patients with essential hypertension.Hypertens. Res.202043651151710.1038/s41440‑020‑0405‑532042143
     [Google Scholar]
  64. YangQ. WangP. CaiY. CuiY. CuiJ. DuX. ChenY. ZhangT. Circulating microRNA-505 may serve as a prognostic biomarker for hypertension-associated endothelial dysfunction and inflammation.Front. Cardiovasc. Med.2022983412110.3389/fcvm.2022.83412135571179
     [Google Scholar]
  65. PrestonR.A. JyW. JimenezJ.J. MauroL.M. HorstmanL.L. ValleM. AimeG. AhnY.S. Effects of severe hypertension on endothelial and platelet microparticles.Hypertension200341221121710.1161/01.HYP.0000049760.15764.2D12574084
     [Google Scholar]
  66. LiangJ. LiY. ChenL. XiaW. WuG. TongX. SuC. HeJ. LinX. TaoJ. Correction to: Systemic microvascular rarefaction is correlated with dysfunction of late endothelial progenitor cells in mild hypertension: a substudy of EXCAVATION-CHN1.J. Transl. Med.20201812610.1186/s12967‑020‑02216‑z31948436
     [Google Scholar]
  67. UmemuraT. SogaJ. HidakaT. TakemotoH. NakamuraS. JitsuikiD. NishiokaK. GotoC. TeragawaH. YoshizumiM. ChayamaK. HigashiY. Aging and hypertension are independent risk factors for reduced number of circulating endothelial progenitor cells.Am. J. Hypertens.200821111203120910.1038/ajh.2008.27818787520
     [Google Scholar]
  68. ShankarishanP. BorahP.K. AhmedG. MahantaJ. Endothelial nitric oxide synthase gene polymorphisms and the risk of hypertension in an Indian population.BioMed Res. Int.2014201411110.1155/2014/79304025165716
     [Google Scholar]
  69. XieX. ShiX. XunX. RaoL. Endothelial nitric oxide synthase gene single nucleotide polymorphisms and the risk of hypertension: A meta-analysis involving 63,258 subjects.Clin. Exp. Hypertens.201739217518210.1080/10641963.2016.123517728287883
     [Google Scholar]
  70. ALrefaiA.A. HabibM.S.E. YaseenR.I. GabrM.K. HabeebR.M. Association of endothelial nitric oxide synthase (eNOS) gene G894T polymorphism with hypertension risk and complications.Mol. Cell. Biochem.20164211-210311010.1007/s11010‑016‑2790‑227557897
     [Google Scholar]
  71. MorrisB.J. ChenR. DonlonT.A. KallianpurK.J. MasakiK.H. WillcoxB.J. Vascular endothelial growth factor receptor 1 gene (FLT1) longevity variant increases lifespan by reducing mortality risk posed by hypertension.Aging (Albany NY)202315103967398310.18632/aging.20472237178326
     [Google Scholar]
  72. CameronA.C. LangN.N. TouyzR.M. Drug treatment of hypertension: focus on vascular health.Drugs201676161529155010.1007/s40265‑016‑0642‑827667708
     [Google Scholar]
  73. MaruhashiT. HigashiY. Current topic of vascular function in hypertension.Hypertens. Res.202346363063710.1038/s41440‑022‑01147‑036604472
     [Google Scholar]
  74. MaruhashiT. HigashiY. Cardiovascular risk in patients receiving antihypertensive drug treatment from the perspective of endothelial function.Hypertens. Res.20224581322133310.1038/s41440‑022‑00936‑x35595983
     [Google Scholar]
  75. TaddeiS. BrunoR.M. Endothelial dysfunction in hypertension.J. Hypertens.20153361137113810.1097/HJH.000000000000060925923727
     [Google Scholar]
  76. GeeL.C. MassimoG. LauC. PrimusC. FernandesD. ChenJ. RathodK.S. HamersA.J.P. FilomenaF. NurediniG. IbrahimA.S. KhambataR.S. GuptaA.K. MoonJ.C. KapilV. AhluwaliaA. Inorganic nitrate attenuates cardiac dysfunction: roles for xanthine oxidoreductase and nitric oxide.Br. J. Pharmacol.2022179204757477710.1111/bph.1563634309015
     [Google Scholar]
  77. ReuleC.A. GoyvaertsB. SchoenC. Effects of an L-arginine-based multi ingredient product on endothelial function in subjects with mild to moderate hypertension and hyperhomocysteinemia - a randomized, double-blind, placebo-controlled, cross-over trial.BMC Complement. Altern. Med.20171719210.1186/s12906‑017‑1603‑928153005
     [Google Scholar]
  78. DowerJ.I. GeleijnseJ.M. GijsbersL. SchalkwijkC. KromhoutD. HollmanP.C. Supplementation of the pure flavonoids epicatechin and quercetin affects some biomarkers of endothelial dysfunction and inflammation in (pre)hypertensive adults: a randomized double-blind, placebo-controlled, crossover trial.J. Nutr.201514571459146310.3945/jn.115.21188825972527
     [Google Scholar]
  79. WagoT. YoshimotoT. AkazaI. TsuchiyaK. IzumiyamaH. DoiM. HirataY. Improvement of endothelial function in patients with hypertension and type 2 diabetes after treatment with telmisartan.Hypertens. Res.201033879680110.1038/hr.2010.10720555330
     [Google Scholar]
  80. De CiuceisC. RossiniC. TincaniA. AiròP. ScarsiM. Agabiti-RoseiC. RuggeriG. CaimiL. RicottaD. Agabiti-RoseiE. RizzoniD. Effect of antihypertensive treatment with lercanidipine on endothelial progenitor cells and inflammation in patients with mild to moderate essential hypertension.Blood Press.201625633734310.1080/08037051.2016.118449527195656
     [Google Scholar]
  81. KorkmazH. KaracaI. KoçM. ÖnalanO. YilmazM. BilenM.N. Early effects of treatment with nebivolol and quinapril on endothelial function in patients with hypertension.Endothelium200815314915510.1080/1062332080212556518568956
     [Google Scholar]
  82. SergM. KampusP. KalsJ. ZaguraM. ZilmerM. ZilmerK. KullisaarT. EhaJ. Nebivolol and metoprolol: long-term effects on inflammation and oxidative stress in essential hypertension.Scand. J. Clin. Lab. Invest.201272542743210.3109/00365513.2012.69199122708640
     [Google Scholar]
  83. HayekS.S. PooleJ.C. NeumanR. MorrisA.A. KhayataM. KavtaradzeN. TopelM.L. BinongoJ.G. LiQ. JonesD.P. WallerE.K. QuyyumiA.A. Differential effects of nebivolol and metoprolol on arterial stiffness, circulating progenitor cells, and oxidative stress.J. Am. Soc. Hypertens.20159320621310.1016/j.jash.2014.12.01325681236
     [Google Scholar]
  84. TangE.H.C. VanhoutteP.M. Endothelial dysfunction: a strategic target in the treatment of hypertension?Pflugers Arch.20104596995100410.1007/s00424‑010‑0786‑420127126
     [Google Scholar]
  85. LiG. XuK. XingW. YangH. LiY. WangX. ZhouJ. AnJ. DongL. ZhangX. WangL. LiJ. GaoF. Swimming exercise alleviates endothelial mitochondrial fragmentation via inhibiting dynamin-related protein-1 to improve vascular function in hypertension.Hypertension20227910e116e12810.1161/HYPERTENSIONAHA.122.1912635950516
     [Google Scholar]
  86. da SilvaM.V.B. da Silva LimaM.A. de FariasL.H. dos SantosV.M. de QueirozT.M. Isolated natural antioxidants as a new possible therapeutic alternative for the treatment of hypertension.Curr. Hypertens. Rev.202319171810.2174/157340211866622100309531737183397
     [Google Scholar]
  87. WuC. ZhangJ. ZhaoY. ChenJ. LiuY. Chinese herbal medicine bushen qinggan formula for blood pressure variability and endothelial injury in hypertensive patients: a randomized controlled pilot clinical trial.Evid. Based Complement. Alternat. Med.201420141710.1155/2014/80417125028590
     [Google Scholar]
  88. SunZ. XuY. AnW. BiS. XuS. ZhangR. CongM. ChenS. Mining important herb combinations of traditional chinese medicine against hypertension based on the symptom-herb network combined with network pharmacology.Evid. Based Complement. Alternat. Med.2022202212010.1155/2022/585089935360657
     [Google Scholar]
  89. BrosoloG. Da PortoA. MarcanteS. PicciA. CapilupiF. CapilupiP. BertinN. VivarelliC. BulfoneL. VaccaA. CatenaC. SechiL.A. Omega-3 fatty acids in arterial hypertension: is there any good news?Int. J. Mol. Sci.20232411952010.3390/ijms2411952037298468
     [Google Scholar]
  90. MaS.M. YangJ.W. TuJ.F. YangN.N. DuY.Z. WangX.R. WangL. HuangJ. LiuC.Z. Gene-level regulation of acupuncture therapy in spontaneously hypertensive rats: a whole transcriptome analysis.Evid. Based Complement. Alternat. Med.2019201911310.1155/2019/954107930906419
     [Google Scholar]
  91. HwangH.S. KimY.S. RyuY.H. LeeJ.E. LeeY.S. YangE.J. ChoiS.M. LeeM.S. Electroacupuncture delays hypertension development through enhancing NO/NOS activity in spontaneously hypertensive rats.Evid. Based Complement. Alternat. Med.20112011113052910.1093/ecam/nen06418955367
     [Google Scholar]
  92. Supa’atI. ZakariaZ. MaskonO. AminuddinA. NordinN.A.M.M. Effects of Swedish massage therapy on blood pressure, heart rate, and inflammatory markers in hypertensive women.Evid. Based Complement. Alternat. Med.201320131810.1155/2013/17185224023571
     [Google Scholar]
  93. Pretnar-OblakJ. SebestjenM. SabovicM. Statin treatment improves cerebral more than systemic endothelial dysfunction in patients with arterial hypertension.Am. J. Hypertens.200821667467810.1038/ajh.2008.15318451811
     [Google Scholar]
  94. HelmstädterJ. FrenisK. FilippouK. GrillA. DibM. KalinovicS. PawelkeF. KusK. Kröller-SchönS. OelzeM. ChlopickiS. SchuppanD. WenzelP. RufW. DruckerD.J. MünzelT. DaiberA. StevenS. Endothelial GLP-1 (glucagon-like peptide-1) receptor mediates cardiovascular protection by liraglutide in mice with experimental arterial hypertension.Arterioscler. Thromb. Vasc. Biol.202040114515810.1161/atv.0000615456.97862.3031747801
     [Google Scholar]
  95. TaddeiS. VirdisA. GhiadoniL. SudanoI. SalvettiA. Effects of antihypertensive drugs on endothelial dysfunction: clinical implications.Drugs200262226528410.2165/00003495‑200262020‑0000311817973
     [Google Scholar]
  96. SantuzziC.H. TiradentesR.V. MengalV. ClaudioE.R.G. MauadH. GouveaS.A. AbreuG.R. Combined aliskiren and L-arginine treatment has antihypertensive effects and prevents vascular endothelial dysfunction in a model of renovascular hypertension.Braz. J. Med. Biol. Res.2015481657610.1590/1414‑431x2014419125493385
     [Google Scholar]
  97. KalinowskiL. DobruckiL.W. Szczepanska-KonkelM. JankowskiM. MartyniecL. AngielskiS. MalinskiT. Third-generation beta-blockers stimulate nitric oxide release from endothelial cells through ATP efflux: a novel mechanism for antihypertensive action.Circulation2003107212747275210.1161/01.CIR.0000066912.58385.DE12742996
     [Google Scholar]
  98. BehmD.J. OgbonnaA. WuC. Burns-KurtisC.L. DouglasS.A. Epoxyeicosatrienoic acids function as selective, endogenous antagonists of native thromboxane receptors: identification of a novel mechanism of vasodilation.J. Pharmacol. Exp. Ther.2009328123123910.1124/jpet.108.14510218836067
     [Google Scholar]
  99. KatoT. IwamaY. OkumuraK. HashimotoH. ItoT. SatakeT. Prostaglandin H2 may be the endothelium-derived contracting factor released by acetylcholine in the aorta of the rat.Hypertension199015547548110.1161/01.HYP.15.5.4752332238
     [Google Scholar]
  100. HeD. PanQ. ChenZ. SunC. ZhangP. MaoA. ZhuY. LiH. LuC. XieM. ZhouY. ShenD. TangC. YangZ. JinJ. YaoX. NiliusB. MaX. Treatment of hypertension by increasing impaired endothelial TRPV 4- KC a2.3 interaction.EMBO Mol. Med.20179111491150310.15252/emmm.20170772528899928
     [Google Scholar]
  101. CostaR.M. CerqueiraD.M. Bruder-NascimentoA. AlvesJ.V. AwataW.M.C. SinghS. KufnerA. PradoD.S. JohnyE. Cifuentes-PaganoE. HawseW.F. DuttaP. PaganoP.J. HoJ. Bruder-NascimentoT. Role of the CCL5 and its receptor, CCR5, in the genesis of aldosterone-induced hypertension, vascular dysfunction, and end-organ damage.Hypertension202481477678610.1161/HYPERTENSIONAHA.123.2188838240165
     [Google Scholar]
  102. XuS. IlyasI. LittleP.J. LiH. KamatoD. ZhengX. LuoS. LiZ. LiuP. HanJ. HardingI.C. EbongE.E. CameronS.J. StewartA.G. WengJ. Endothelial dysfunction in atherosclerotic cardiovascular diseases and beyond: from mechanism to pharmacotherapies.Pharmacol. Rev.202173392496710.1124/pharmrev.120.00009634088867
     [Google Scholar]
  103. FraineauS. PaliiC.G. AllanD.S. BrandM. Epigenetic regulation of endothelial-cell-mediated vascular repair.FEBS J.201528291605162910.1111/febs.1318325546332
     [Google Scholar]
  104. LeeH.Y. OhB.H. Aging and arterial stiffness.Circ. J.201074112257226210.1253/circj.CJ‑10‑091020962429
     [Google Scholar]
  105. KimH.L. Arterial stiffness and hypertension.Clin. Hypertens.20232913110.1186/s40885‑023‑00258‑138037153
     [Google Scholar]
  106. WeberT. The role of arterial stiffness and central hemodynamics in heart failureInt. J. Heart Fail.20202420923010.36628/ijhf.2020.0029
     [Google Scholar]
  107. KimH.L. KimS.H. Pulse wave velocity in atherosclerosis.Front. Cardiovasc. Med.201964110.3389/fcvm.2019.0004131024934
     [Google Scholar]
  108. KimH.L. WeberT. Pulsatile hemodynamics and coronary artery disease.Korean Circ. J.2021511188189810.4070/kcj.2021.022734595882
     [Google Scholar]
  109. ManriqueC. LastraG. GardnerM. SowersJ.R. The renin angiotensin aldosterone system in hypertension: roles of insulin resistance and oxidative stress.Med. Clin. North Am.200993356958210.1016/j.mcna.2009.02.01419427492
     [Google Scholar]
  110. Martinez-LemusL.A. HillM.A. MeiningerG.A. The plastic nature of the vascular wall: a continuum of remodeling events contributing to control of arteriolar diameter and structure.Physiology2009241455710.1152/physiol.00029.200819196651
     [Google Scholar]
  111. RennaN.F. de Las HerasN. MiatelloR.M. Pathophysiology of vascular remodeling in hypertension.Int. J. Hypertens.2013201380835323970958
     [Google Scholar]
  112. ElmarasiM. ElmakatyI. ElsayedB. ElsayedA. ZeinJ.A. BoudakaA. EidA.H. Phenotypic switching of vascular smooth muscle cells in atherosclerosis, hypertension, and aortic dissection.J. Cell. Physiol.20242394e3120010.1002/jcp.3120038291732
     [Google Scholar]
  113. BadranA. NasserS.A. MesmarJ. El-YazbiA.F. BittoA. FardounM.M. BaydounE. EidA.H. Reactive oxygen species: modulators of phenotypic switch of vascular smooth muscle cells.Int. J. Mol. Sci.20202122876410.3390/ijms2122876433233489
     [Google Scholar]
  114. ChirinosJ.A. ZambranoJ.P. ChakkoS. VeeraniA. SchobA. WillensH.J. PerezG. MendezA.J. Aortic pressure augmentation predicts adverse cardiovascular events in patients with established coronary artery disease.Hypertension200545598098510.1161/01.HYP.0000165025.16381.4415837821
     [Google Scholar]
  115. LaurentS. CockcroftJ. Van BortelL. BoutouyrieP. GiannattasioC. HayozD. PannierB. VlachopoulosC. WilkinsonI. Struijker-BoudierH. Expert consensus document on arterial stiffness: methodological issues and clinical applications.Eur. Heart J.200627212588260510.1093/eurheartj/ehl25417000623
     [Google Scholar]
  116. van der Heijden-SpekJ.J. StaessenJ.A. FagardR.H. HoeksA.P. BoudierH.A.S. Van BortelL.M. Effect of age on brachial artery wall properties differs from the aorta and is gender dependent: a population study.Hypertension200035263764210.1161/01.HYP.35.2.63710679510
     [Google Scholar]
  117. KangJ. KimH.L. LimW.H. SeoJ.B. ZoJ.H. KimM.A. KimS.H. Relationship between brachial-ankle pulse wave velocity and invasively measured aortic pulse pressure.J. Clin. Hypertens. (Greenwich)201820346246810.1111/jch.1320029370481
     [Google Scholar]
  118. IshidaK. MorimotoS. HoriuchiS. KimuraM. IshikawaT. KimuraS. YamashitaK. TakanoN. SekiY. BokudaK. SasakiN. WatanabeD. IchiharaA. Comparison of the usefulness of the cardio-ankle vascular index and augmentation index as an index of arteriosclerosis in patients with essential hypertension.Hypertens. Res.202245345546310.1038/s41440‑021‑00823‑x34934159
     [Google Scholar]
  119. SunC.K. Cardio-ankle vascular index (CAVI) as an indicator of arterial stiffness.Integr. Blood Press. Control20136273810.2147/IBPC.S3442323667317
     [Google Scholar]
  120. WilliamsB. ManciaG. SpieringW. Agabiti RoseiE. AziziM. BurnierM. ClementD.L. CocaA. de SimoneG. DominiczakA. KahanT. MahfoudF. RedonJ. RuilopeL. ZanchettiA. KerinsM. KjeldsenS.E. KreutzR. LaurentS. LipG.Y.H. McManusR. NarkiewiczK. RuschitzkaF. SchmiederR.E. ShlyakhtoE. TsioufisC. AboyansV. DesormaisI. De BackerG. HeagertyA.M. AgewallS. BochudM. BorghiC. BoutouyrieP. BrguljanJ. BuenoH. CaianiE.G. CarlbergB. ChapmanN. CífkováR. ClelandJ.G.F. ColletJ-P. ComanI.M. de LeeuwP.W. DelgadoV. DendaleP. DienerH-C. DorobantuM. FagardR. FarsangC. FerriniM. GrahamI.M. GrassiG. HallerH. HobbsF.D.R. JelakovicB. JenningsC. KatusH.A. KroonA.A. LeclercqC. LovicD. LurbeE. ManolisA.J. McDonaghT.A. MesserliF. MuiesanM.L. NixdorffU. OlsenM.H. ParatiG. PerkJ. PiepoliM.F. PoloniaJ. PonikowskiP. RichterD.J. RimoldiS.F. RoffiM. SattarN. SeferovicP.M. SimpsonI.A. Sousa-UvaM. StantonA.V. van de BorneP. VardasP. VolpeM. WassmannS. WindeckerS. ZamoranoJ.L. WindeckerS. AboyansV. AgewallS. BarbatoE. BuenoH. CocaA. ColletJ-P. ComanI.M. DeanV. DelgadoV. FitzsimonsD. GaemperliO. HindricksG. IungB. JüniP. KatusH.A. KnuutiJ. LancellottiP. LeclercqC. McDonaghT.A. PiepoliM.F. PonikowskiP. RichterD.J. RoffiM. ShlyakhtoE. SimpsonI.A. Sousa-UvaM. ZamoranoJ.L. TsioufisC. LurbeE. KreutzR. BochudM. RoseiE.A. JelakovicB. AziziM. JanuszewicsA. KahanT. PoloniaJ. van de BorneP. WilliamsB. BorghiC. ManciaG. ParatiG. ClementD.L. CocaA. ManolisA. LovicD. BenkheddaS. ZelveianP. SiostrzonekP. NajafovR. PavlovaO. De PauwM. Dizdarevic-HudicL. RaevD. KarpettasN. LinhartA. OlsenM.H. ShakerA.F. ViigimaaM. MetsärinneK. VavlukisM. HalimiJ-M. PagavaZ. SchunkertH. ThomopoulosC. PállD. AndersenK. ShechterM. MercuroG. BajraktariG. RomanovaT. TrušinskisK. SaadeG.A. SakalyteG. NoppeS. DeMarcoD.C. CarausA. WittekoekJ. AksnesT.A. JankowskiP. PoloniaJ. VinereanuD. BaranovaE.I. FoscoliM. DikicA.D. FilipovaS. FrasZ. Bertomeu-MartínezV. CarlbergB. BurkardT. SdiriW. AydogduS. SirenkoY. BradyA. WeberT. LazarevaI. BackerT.D. SokolovicS. JelakovicB. WidimskyJ. ViigimaaM. PörstiI. DenolleT. KrämerB.K. StergiouG.S. ParatiG. TrušinskisK. MiglinasM. GerdtsE. TykarskiA. de Carvalho RodriguesM. DorobantuM. ChazovaI. LovicD. FilipovaS. BrguljanJ. SeguraJ. GottsäterA. Pechère-BertschiA. ErdineS. SirenkoY. BradyA. 2018 ESC/ESH Guidelines for the management of arterial hypertension.Eur. Heart J.201839333021310410.1093/eurheartj/ehy33930165516
     [Google Scholar]
  121. NajjarS.S. ScuteriA. ShettyV. WrightJ.G. MullerD.C. FlegJ.L. SpurgeonH.P. FerrucciL. LakattaE.G. Pulse wave velocity is an independent predictor of the longitudinal increase in systolic blood pressure and of incident hypertension in the baltimore longitudinal study of aging.J. Am. Coll. Cardiol.200851141377138310.1016/j.jacc.2007.10.06518387440
     [Google Scholar]
  122. LeeS.J. AvolioA. SeoD.C. KimB.S. KangJ.H. LeeM.Y. SungK.C. Relationship between brachial-ankle pulse wave velocity and incident hypertension according to 2017 ACC/AHA high blood pressure guidelines.J. Am. Heart Assoc.2019816e01301910.1161/JAHA.119.01301931412746
     [Google Scholar]
  123. VlachopoulosC. AznaouridisK. StefanadisC. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis.J. Am. Coll. Cardiol.201055131318132710.1016/j.jacc.2009.10.06120338492
     [Google Scholar]
  124. ChouY.T. ChenH.Y. ShenW.C. WuI.H. SuF.L. LeeW.H. HsuH.L. TaiJ.T. LiC.Y. ChaoT.H. Blood pressure levels within normotensive range are independently associated with increased risk of arterial stiffness in adults without hypertension or prehypertension.Nutr. Metab. Cardiovasc. Dis.202333122363237110.1016/j.numecd.2023.08.00937788952
     [Google Scholar]
  125. TomiyamaH. KomatsuS. ShiinaK. MatsumotoC. KimuraK. FujiiM. TakahashiL. ChikamoriT. YamashinaA. Effect of wave reflection and arterial stiffness on the risk of development of hypertension in japanese men.J. Am. Heart Assoc.2018710e00817510.1161/JAHA.117.00817529739795
     [Google Scholar]
  126. AgbajeA.O. Arterial stiffness precedes hypertension and metabolic risks in youth: a review.J. Hypertens.202240101887189610.1097/HJH.000000000000323935822587
     [Google Scholar]
  127. KimH.L. LimW.H. SeoJ.B. KimS.H. ZoZ.H. KimM.A. Prediction of cardiovascular events using brachial-ankle pulse wave velocity in hypertensive patients.J. Clin. Hypertens. (Greenwich)20202291659166510.1111/jch.1399232777179
     [Google Scholar]
  128. BoutouyrieP. TropeanoA.I. AsmarR. GautierI. BenetosA. LacolleyP. LaurentS. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study.Hypertension2002391101510.1161/hy0102.09903111799071
     [Google Scholar]
  129. KimS.H. ShinC. KimS. KimJ.S. LimS.Y. SeoH.S. LimH.E. SungK.C. ChoG.Y. LeeS.K. KimY.H. Prevalence of isolated nocturnal hypertension and development of arterial stiffness, left ventricular hypertrophy, and silent cerebrovascular lesions: the KoGES (korean genome and epidemiology study).J. Am. Heart Assoc.20221119e02564110.1161/JAHA.122.02564136193933
     [Google Scholar]
  130. MunakataM. NunokawaT. YoshinagaK. ToyotaT. GroupJ.T.S. Brachial-ankle pulse wave velocity is an independent risk factor for microalbuminuria in patients with essential hypertension-a Japanese trial on the prognostic implication of pulse wave velocity (J-TOPP).Hypertens. Res.200629751552110.1291/hypres.29.51517044664
     [Google Scholar]
  131. MunakataM. KonnoS. MiuraY. YoshinagaK. GroupJ.T.S. Prognostic significance of the brachial–ankle pulse wave velocity in patients with essential hypertension: final results of the J-TOPP study.Hypertens. Res.201235883984210.1038/hr.2012.5322534520
     [Google Scholar]
  132. FuT. PanY. SunQ. ZhangX. CongT. JiangY. LiuY. Associations of brachial-ankle pulse wave velocity with left atrial stiffness and left atrial phasic function in inpatients with hypertension.Hypertens. Res.202346102378238710.1038/s41440‑023‑01390‑z37532950
     [Google Scholar]
  133. LiY.L. SongX. RenJ.C. LiX.G. HouS.A. MiaoC. Correlation analysis of ankle-brachial index and brachial-ankle pulse wave velocity with cardiac structures and functions in patients with essential hypertension.Eur. Rev. Med. Pharmacol. Sci.201721245798580429272016
     [Google Scholar]
  134. MatsumotoC. TomiyamaH. YamadaJ. YoshidaM. ShiinaK. YamashinaA. Brachial-ankle pulse wave velocity as a marker of subclinical organ damage in middle-aged patients with hypertension.J. Cardiol.200851316317010.1016/j.jjcc.2008.02.00418522791
     [Google Scholar]
  135. SakuragiS. MaruoT. TaniguchiM. NagaseS. NakamuraK. KusanoK.F. OheT. Radial augmentation index associated with increase in B-type natriuretic peptide in patients with hypertension.Int. J. Cardiol.2008130341441910.1016/j.ijcard.2007.08.12918177956
     [Google Scholar]
  136. SunJ. WangS. LiM. SuY. MaS. ZhangY. ZhangA. CaiS. ChengB. BaoQ. ZhuP. The high normal ankle brachial index is associated with left ventricular hypertrophy in hypertension patients among the Han Chinese.J. Clin. Hypertens. (Greenwich)20212391758176610.1111/jch.1432834297892
     [Google Scholar]
  137. MorillasP. CorderoA. BertomeuV. Gonzalez-JuanateyJ.R. QuilesJ. GuindoJ. SoriaF. MazónP. NietoV. AnguitaM. González-MaquedaI. Prognostic value of low ankle–brachial index in patients with hypertension and acute coronary syndromes.J. Hypertens.200927234134710.1097/HJH.0b013e328319919319226706
     [Google Scholar]
  138. LuoY.Y. LiJ. XinY. ZhengL.Q. YuJ.M. HuD.Y. Risk factors of peripheral arterial disease and relationship between low ankle brachial index and mortality from all-cause and cardiovascular disease in Chinese patients with hypertension.J. Hum. Hypertens.200721646146610.1038/sj.jhh.100217717344909
     [Google Scholar]
  139. OkuraT. WatanabeS. KurataM. ManabeS. KoresawaM. IritaJ. EnomotoD. MiyoshiK. FukuokaT. HigakiJ. Relationship between cardio-ankle vascular index (CAVI) and carotid atherosclerosis in patients with essential hypertension.Hypertens. Res.200730433534010.1291/hypres.30.33517541212
     [Google Scholar]
  140. VerdecchiaP. SchillaciG. ReboldiG. FranklinS.S. PorcellatiC. Different prognostic impact of 24-hour mean blood pressure and pulse pressure on stroke and coronary artery disease in essential hypertension.Circulation2001103212579258410.1161/01.CIR.103.21.257911382727
     [Google Scholar]
  141. ZhangS. Zhong, Y.; Wu, S.; Wu, H.; Cai, J.; Zhang, W.; Group, S. S. Intensive blood pressure control on arterial stiffness among older patients with hypertension.Chin. Med. J. (Engl.)202310781087
     [Google Scholar]
  142. ManciaG. KreutzR. BrunströmM. BurnierM. GrassiG. JanuszewiczA. MuiesanM.L. TsioufisK. Agabiti-RoseiE. AlgharablyE.A.E. AziziM. BenetosA. BorghiC. HitijJ.B. CifkovaR. CocaA. CornelissenV. CruickshankJ.K. CunhaP.G. DanserA.H.J. PinhoR.M. DellesC. DominiczakA.F. DorobantuM. DoumasM. Fernández-AlfonsoM.S. HalimiJ.M. JáraiZ. JelakovićB. JordanJ. KuznetsovaT. LaurentS. LovicD. LurbeE. MahfoudF. ManolisA. MiglinasM. NarkiewiczK. NiiranenT. PalatiniP. ParatiG. PathakA. PersuA. PoloniaJ. RedonJ. SarafidisP. SchmiederR. SpronckB. StabouliS. StergiouG. TaddeiS. ThomopoulosC. TomaszewskiM. Van de BorneP. WannerC. WeberT. WilliamsB. ZhangZ.Y. KjeldsenS.E. 2023 ESH guidelines for the management of arterial hypertension the task force for the management of arterial hypertension of the european society of hypertension.J. Hypertens.202341121874207110.1097/HJH.000000000000348037345492
     [Google Scholar]
  143. JinL. ChenJ. ZhangM. ShaL. CaoM. TongL. ChenQ. ShenC. DuL. LiZ. LiuL. Relationship of arterial stiffness and central hemodynamics with cardiovascular risk in hypertension.Am. J. Hypertens.202336420120810.1093/ajh/hpad00536645322
     [Google Scholar]
  144. KhattarR.S. SwalesJ.D. DoreC. SeniorR. LahiriA. Effect of aging on the prognostic significance of ambulatory systolic, diastolic, and pulse pressure in essential hypertension.Circulation2001104778378910.1161/hc3201.09422711502703
     [Google Scholar]
  145. ZhangY. WangM. JingX. CaoQ. ZhangP. WangY. LiuF. XuX. WangJ. HeL. XuF. Endothelial function and arterial stiffness indexes in subjects with carotid plaque and carotid plaque length: A subgroup analysis showing the relationship with hypertension and diabetes.J. Stroke Cerebrovasc. Dis.202332310698610.1016/j.jstrokecerebrovasdis.2023.10698636669372
     [Google Scholar]
  146. AltayE. KıztanırH. KösgerP. CetinN. SuluA. TufanA.K. OzenH. UcarB. Evaluation of arterial stiffness and carotid intima-media thickness in children with primary and renal hypertension.Pediatr. Cardiol.2023441546610.1007/s00246‑022‑03012‑w36169696
     [Google Scholar]
  147. AgbajeA.O. BarkerA.R. TuomainenT.P. Effects of arterial stiffness and carotid intima-media thickness progression on the risk of overweight/obesity and elevated blood pressure/hypertension: a cross-lagged cohort study.Hypertension202279115916910.1161/HYPERTENSIONAHA.121.1844934784721
     [Google Scholar]
  148. MyslinskiW. StanekA. FeldoM. MosiewiczJ. Ankle-brachial index as the best predictor of first acute coronary syndrome in patients with treated systemic hypertension.BioMed Res. Int.202020201810.1155/2020/647109832724805
     [Google Scholar]
  149. SallesG.F. CardosoC.R.L. FiszmanR. MuxfeldtE.S. Prognostic importance of baseline and serial changes in microalbuminuria in patients with resistant hypertension.Atherosclerosis2011216119920410.1016/j.atherosclerosis.2011.01.02621315356
     [Google Scholar]
  150. TomiyamaH. VlachopoulosC. XaplanterisP. NakanoH. ShiinaK. IshizuT. KohroT. HigashiY. TakaseB. SuzukiT. YamazakiT. FurumotoT. KarioK. InoueT. KobaS. TakemotoY. HanoT. SataM. IshibashiY. NodeK. TanakaA. MaemuraK. OhyaY. FurukawaT. ItoH. OhkumaT. NinomiyaT. ChikamoriT. YamashinaA. UedaS. Usefulness of the SAGE score to predict elevated values of brachial-ankle pulse wave velocity in Japanese subjects with hypertension.Hypertens. Res.202043111284129210.1038/s41440‑020‑0472‑732457429
     [Google Scholar]
  151. WuS. TianX. ChenS. ZhangY. ZhangX. XuQ. WangA. Arterial stiffness and blood pressure in treated hypertension: a longitudinal study.J. Hypertens.202341576877410.1097/HJH.000000000000340036883462
     [Google Scholar]
  152. LaurentS. ChatellierG. AziziM. CalvetD. ChoukrounG. DanchinN. DelsartP. GirerdX. GosseP. KhettabH. LondonG. MouradJ.J. PannierB. PereiraH. StephanD. ValensiP. CunhaP. NarkiewiczK. BrunoR.M. BoutouyrieP. InvestigatorsS. SPARTE study: normalization of arterial stiffness and cardiovascular events in patients with hypertension at medium to very high risk.Hypertension202178498399510.1161/HYPERTENSIONAHA.121.1757934455813
     [Google Scholar]
  153. FigueroaA. WongA. KalfonR. Effects of watermelon supplementation on aortic hemodynamic responses to the cold pressor test in obese hypertensive adults.Am. J. Hypertens.201427789990610.1093/ajh/hpt29524572702
     [Google Scholar]
  154. LopesS. Mesquita-BastosJ. GarciaC. LeitãoC. RibauV. TeixeiraM. BertoquiniS. RibeiroI.P. de MeloJ.B. OliveiraJ. FigueiredoD. GuimarãesG.V. PescatelloL.S. PoloniaJ. AlvesA.J. RibeiroF. Aerobic exercise improves central blood pressure and blood pressure variability among patients with resistant hypertension: results of the EnRicH trial.Hypertens. Res.20234661547155710.1038/s41440‑023‑01229‑736813985
     [Google Scholar]
  155. VamvakisA. GkaliagkousiE. LazaridisA. GrammatikopoulouM.G. TriantafyllouA. NikolaidouB. KoletsosN. AnyfantiP. TzimosC. ZebekakisP. DoumaS. Impact of intensive lifestyle treatment (diet plus exercise) on endothelial and vascular function, arterial stiffness and blood pressure in stage 1 hypertension: results of the hintreat randomized controlled trial.Nutrients2020125132610.3390/nu1205132632392715
     [Google Scholar]
  156. LopesS. AfreixoV. TeixeiraM. GarciaC. LeitãoC. GouveiaM. FigueiredoD. AlvesA.J. PoloniaJ. OliveiraJ. Mesquita-BastosJ. RibeiroF. Exercise training reduces arterial stiffness in adults with hypertension: a systematic review and meta-analysis.J. Hypertens.202139221422210.1097/HJH.000000000000261932833924
     [Google Scholar]
  157. SonW.M. SungK.D. ChoJ.M. ParkS.Y. Combined exercise reduces arterial stiffness, blood pressure, and blood markers for cardiovascular risk in postmenopausal women with hypertension.Menopause201724326226810.1097/GME.000000000000076527779565
     [Google Scholar]
  158. ShibataT. TsutsumiJ. HasegawaJ. SatoN. MurashimaE. MoriC. HongoK. YoshimuraM. Effects of add-on therapy consisting of a selective mineralocorticoid receptor blocker on arterial stiffness in patients with uncontrolled hypertension.Intern. Med.201554131583158910.2169/internalmedicine.54.342726134187
     [Google Scholar]
  159. AnanF. TakahashiN. OoieT. YufuK. HaraM. NakagawaM. YonemochiH. SaikawaT. YoshimatsuH. Effects of valsartan and perindopril combination therapy on left ventricular hypertrophy and aortic arterial stiffness in patients with essential hypertension.Eur. J. Clin. Pharmacol.2005615-635335910.1007/s00228‑005‑0931‑815918057
     [Google Scholar]
  160. MiyoshiT. MurakamiT. SakuragiS. DoiM. NanbaS. MimaA. TominagaY. OkaT. KajikawaY. NakamuraK. ItoH. Comparable effect of aliskiren or a diuretic added on an angiotensin II receptor blocker on augmentation index in hypertension: a multicentre, prospective, randomised study.Open Heart201741e00059110.1136/openhrt‑2017‑00059128409014
     [Google Scholar]
  161. AsmarR.G. KerihuelJ.C. GirerdX.J. SafarM.E. Effect of bisoprolol on blood pressure and arterial hemodynamics in systemic hypertension.Am. J. Cardiol.1991681616410.1016/0002‑9149(91)90711‑S1676238
     [Google Scholar]
  162. KampusP. SergM. KalsJ. ZaguraM. MudaP. KaruK. ZilmerM. EhaJ. Differential effects of nebivolol and metoprolol on central aortic pressure and left ventricular wall thickness.Hypertension20115761122112810.1161/HYPERTENSIONAHA.110.15550721536983
     [Google Scholar]
  163. ZhangJ. WangY. HuH. YangX. TianZ. LiuD. GuG. ZhengH. XieR. CuiW. Early intervention of long-acting nifedipine GITS reduces brachial–ankle pulse wave velocity and improves arterial stiffness in Chinese patients with mild hypertension: a 24-week, single-arm, open-label, prospective study.Drug Des. Devel. Ther.2016103399340610.2147/DDDT.S11722127799740
     [Google Scholar]
  164. GepnerA.D. TedlaY. ColangeloL.A. TattersallM.C. KorcarzC.E. KaufmanJ.D. LiuK. BurkeG.L. SheaS. GreenlandP. SteinJ.H. Progression of carotid arterial stiffness with treatment of hypertension over 10 years.Hypertension2017691879510.1161/HYPERTENSIONAHA.116.0840227849564
     [Google Scholar]
  165. WallbachM. LehnigL.Y. SchroerC. HelmsH.J. LüdersS. PatschanD. PatschanS. MüllerG.A. WachterR. KoziolekM.J. Effects of baroreflex activation therapy on arterial stiffness and central hemodynamics in patients with resistant hypertension.J. Hypertens.201533118118610.1097/HJH.000000000000036125232758
     [Google Scholar]
  166. HeringD. LambertE.A. MarusicP. Ika-SariC. WaltonA.S. KrumH. SobotkaP.A. MahfoudF. BöhmM. LambertG.W. EslerM.D. SchlaichM.P. Renal nerve ablation reduces augmentation index in patients with resistant hypertension.J. Hypertens.20133191893190010.1097/HJH.0b013e3283622e5823697964
     [Google Scholar]
  167. HummelS.L. SeymourE.M. BrookR.D. KoliasT.J. ShethS.S. RosenblumH.R. WellsJ.M. WederA.B. Low-sodium dietary approaches to stop hypertension diet reduces blood pressure, arterial stiffness, and oxidative stress in hypertensive heart failure with preserved ejection fraction.Hypertension20126051200120610.1161/HYPERTENSIONAHA.112.20270523033371
     [Google Scholar]
  168. TocciG. Biondi-ZoccaiG. ForteM. GalloG. NardoianniG. FioriE. D’AmbrosioL. Di PietroR. StefaniniG. CannataF. RoccoE. SimeoneB. SartoG. SchironeL. D’AmicoA. PeruzziM. NocellaC. VolpeM. RubattuS. Effects of two-month treatment with a mixture of natural activators of autophagy on oxidative stress and arterial stiffness in patients with essential hypertension: A pilot study.Nutr. Metab. Cardiovasc. Dis.202333112287229310.1016/j.numecd.2023.07.02637580230
     [Google Scholar]
  169. GaoJ. AkbariA. WangT. Green tea could improve elderly hypertension by modulating arterial stiffness, the activity of the renin/angiotensin/aldosterone axis, and the sodium–potassium pumps in old male rats.J. Food Biochem.20224612e1439810.1111/jfbc.1439836181277
     [Google Scholar]
  170. MucaloI. JovanovskiE. RahelićD. BožikovV. RomićŽ. VuksanV. Effect of american ginseng (Panax quinquefolius L.) On arterial stiffness in subjects with type-2 diabetes and concomitant hypertension.J. Ethnopharmacol.2013150114815310.1016/j.jep.2013.08.01523973636
     [Google Scholar]
  171. TerentevaN. ChernykhO. Sanchez-GonzalezM.A. WongA. Acupuncture therapy improves vascular hemodynamics and stiffness in middle-age hypertensive individuals.Complement. Ther. Clin. Pract.201830141810.1016/j.ctcp.2017.11.00229389472
     [Google Scholar]
  172. PatilS.G. BiradarM.S. KhodeV. VadirajaH.S. PatilN.G. RaghavendraR.M. Effectiveness of yoga on arterial stiffness: A systematic review.Complement. Ther. Med.20205210248410.1016/j.ctim.2020.10248432951734
     [Google Scholar]
  173. Cavero-RedondoI. Saz-LaraA. Lugones-SánchezC. Pozuelo-CarrascosaD.P. Gómez-SánchezL. López-GilJ.F. García-OrtizL. BrunoR.M. Gómez-MarcosM.Á. Comparative effect of antihypertensive drugs in improving arterial stiffness in adults with hypertension (RIGIPREV study). A network meta-analysis.Front. Pharmacol.202314122579510.3389/fphar.2023.122579537724181
     [Google Scholar]
  174. AsmarR. HuguesC. PannierB. DaouJ. SafarM. E. Duration of action of bisoprolol after cessation of a 4 week treatment and its influence on pulse wave velocity and aortic diameter: a pilot study in hypertensive patients.Eur Heart J1987811512010.1093/eurheartj/8.suppl_M.115
     [Google Scholar]
  175. ShahinY. KhanJ.A. ChetterI. Angiotensin converting enzyme inhibitors effect on arterial stiffness and wave reflections: A meta-analysis and meta-regression of randomised controlled trials.Atherosclerosis20122211183310.1016/j.atherosclerosis.2011.12.00522209214
     [Google Scholar]
  176. SirenkoY. RekovetsO. “The impact of statins addind to the fixed combination antihypertensive therapy on the arterial stiffness in patients with moderate and severe hypertension”.Int. J. Cardio. Cardiovas. Risk. Prev.20231820019010.1016/j.ijcrp.2023.20019037325253
     [Google Scholar]
  177. FokH. GuilcherA. LiY. BrettS. ShahA. ClappB. ChowienczykP. Augmentation pressure is influenced by ventricular contractility/relaxation dynamics: novel mechanism of reduction of pulse pressure by nitrates.Hypertension20146351050105510.1161/HYPERTENSIONAHA.113.0295524516104
     [Google Scholar]
  178. BoutouyrieP. ChowienczykP. HumphreyJ.D. MitchellG.F. Arterial stiffness and cardiovascular risk in hypertension.Circ. Res.2021128786488610.1161/CIRCRESAHA.121.31806133793325
     [Google Scholar]
/content/journals/cmc/10.2174/0109298673311734240718064511
Loading
Markers of Vascular Dysfunction in Hypertension
Curr. Med. Chem. 32, 8811 (2025); https://doi.org/10.2174/0109298673311734240718064511
/content/journals/cmc/10.2174/0109298673311734240718064511
/content/journals/cmc/10.2174/0109298673311734240718064511
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): arterial stiffness; endothelial dysfunction; Hypertension; pathophysiology; prognosis; treatment; vascular dysfunction

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test